Evidence map›Paper›PMID 35615418›Full record

ArticleERJ open research2022

ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly.

Sabina A Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, Wim A Wuyts, Marlies S Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A Renzoni, Marcel Veltkamp, Paolo Spagnolo and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 17 institutions in 10 countries.

Sabina A GulerDept of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Sara Cuevas-OcañaNottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham, UK.
Mouhamad NasserDept of Respiratory Medicine, National Reference Center for Rare Pulmonary Diseases, Hospices Civils de Lyon, Lyon, France.
Wim A WuytsUnit for Interstitial Lung Disease, Dept of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-9648-3497
Marlies S WijsenbeekCenter for Interstitial Lung Diseases and Sarcoidosis, Dept of Respiratory Medicine, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Antoine FroidureService de Pneumologie, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale, UCLouvain, Brussels, Belgium.
Elena BargagliDept of Medical Sciences, Surgery and Neurosciences, Respiratory Medicine, Siena University, Siena, Italy.
Elisabetta A RenzoniInterstitial Lung Disease Unit, Royal Brompton and Harefield (Guy's and St Thomas' NHS Foundation Trust), Margaret Turner Warwick Centre for Fibrosing Lung Diseases, NHLI, Imperial College, London, UK.
Marcel VeltkampInterstitial Lung Diseases Centre of Excellence, St Antonius Hospital, Nieuwegein, The Netherlands.
Paolo SpagnoloRespiratory Disease Unit, Dept of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.
Hilario NunesService de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares, Hôpital Avicenne, Assistance Publique Hôpitaux de Paris, Université Sorbonne Paris Nord, Bobigny, France.
Cormac McCarthyUCD School of Medicine, Education and Research Centre, St Vincent's University Hospital, Dublin, Ireland.
Maria Molina-MolinaDept of Pneumology, Unit of Interstitial Lung Diseases, University Hospital of Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain.
Francesco BonellaCenter for Interstitial and Rare Lung Diseases, Ruhrlandklinik University Hospital, Duisburg-Essen University, Essen, Germany.ORCID https://orcid.org/0000-0001-7579-9767
Venerino PolettiDipartimento Malattie dell'Apparato Respiratorio e del Torace Ospedale GB Morgagni-Forlí (FC)/University of Bologna, Bologna, Italy.
Michael KreuterCenter for Interstitial and Rare Lung Diseases, and Interdisciplinary Center for Sarcoidosis, Pneumology, Thoraxklinik, University Hospital Heidelberg and German Center for Lung Research, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-4402-2159
Katerina M AntoniouLaboratory of Molecular and Cellular Pneumonology Laboratory, Dept of Respiratory Medicine, School of Medicine, University of Crete, Crete, Greece.
Catharina C MoorCenter for Interstitial Lung Diseases and Sarcoidosis, Dept of Respiratory Medicine, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5295-2877
Erasmus MC · NLCliniques Universitaires Saint-Luc · BEGuy's and St Thomas' NHS Foundation Trust · GBHeidelberg University · DEHospices Civils de Lyon · FRInstitut d'Investigació Biomédica de Bellvitge · ESKU Leuven · BERuhrlandklinik · DESorbonne Université · FRSt. Vincent's University Hospital · IEUniversity Medical Center Utrecht · NLUniversity of Bern · CHUniversity of Bologna · ITUniversity of Crete · GRUniversity of Nottingham · GBUniversity of Padua · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article provides an overview of scientific highlights in the field of interstitial lung disease (ILD), presented at the virtual European Respiratory Society Congress 2021. A broad range of topics was discussed this year, ranging from translational and genetic aspects to novel innovations with the potential to improve the patient pathway. Early Career Members summarise a selection of interesting findings from different congress sessions, together with the leadership of Assembly 12 - Interstitial Lung Disease.

Identifiers

PMID35615418
PMCPMC9124869
OpenAlexW4205492240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.